Kun Xu

2.0k total citations · 1 hit paper
29 papers, 630 citations indexed

About

Kun Xu is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Kun Xu has authored 29 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 9 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Kun Xu's work include SARS-CoV-2 and COVID-19 Research (15 papers), Respiratory viral infections research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Kun Xu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), Respiratory viral infections research (4 papers) and COVID-19 Clinical Research Studies (4 papers). Kun Xu collaborates with scholars based in China, Czechia and United States. Kun Xu's co-authors include George F. Gao, Kefang Liu, William J. Liu, Wenjie Tan, Min Zhao, Gary Wong, Lianpan Dai, Yi Shi, Yuhai Bi and Qingrui Huang and has published in prestigious journals such as ACS Nano, Nature Immunology and Journal of Virology.

In The Last Decade

Kun Xu

25 papers receiving 616 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV

2016 274 citations William J. Liu, Min Zhao et al. Antiviral Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kun Xu China	10	500	159	115	101	82	29	630
Thomas Theo Brehm Germany	17	458 0.9×	127 0.8×	126 1.1×	141 1.4×	111 1.4×	63	785
Owen TY Tsang Hong Kong	8	646 1.3×	72 0.5×	69 0.6×	62 0.6×	53 0.6×	10	717
Zoë L. Lyski United States	12	411 0.8×	44 0.3×	34 0.3×	42 0.4×	64 0.8×	21	482
Marie-Josée Wendling France	10	336 0.7×	58 0.4×	39 0.3×	249 2.5×	55 0.7×	22	639
Sarah Shalhoub Canada	10	311 0.6×	45 0.3×	69 0.6×	138 1.4×	36 0.4×	18	456
Michelle M. Packard United States	7	575 1.1×	79 0.5×	96 0.8×	169 1.7×	63 0.8×	11	760
Liise-anne Pirofski United States	12	548 1.1×	69 0.4×	37 0.3×	467 4.6×	77 0.9×	34	745
Sami Al Hajjar Saudi Arabia	10	545 1.1×	69 0.4×	23 0.2×	280 2.8×	36 0.4×	14	752
Aktham Haddadin Jordan	10	511 1.0×	46 0.3×	38 0.3×	83 0.8×	19 0.2×	11	627
Alvin X. Han Netherlands	14	233 0.5×	142 0.9×	54 0.5×	231 2.3×	60 0.7×	35	561

Countries citing papers authored by Kun Xu

Since Specialization

Citations

This map shows the geographic impact of Kun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Xu more than expected).

Fields of papers citing papers by Kun Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Xu. The network helps show where Kun Xu may publish in the future.

Co-authorship network of co-authors of Kun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Xu. A scholar is included among the top collaborators of Kun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Xu. Kun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Mengyu, Jiufeng Sun, Jie Mei, et al.. (2025). Pulmonary Surfactant Protein-Hitchhiking Inhalable Vaccines Augment Mucosal and Systemic Antiviral Immunity. ACS Nano. 19(43). 37895–37909.

Ma, B.M., Yao Wang, Fei Ling, et al.. (2025). CRISPR/CasRx: A novel antiviral approach to combat largemouth bass (Micropterus salmoides) Rhabdovirus infections. Aquaculture. 599. 742189–742189.

Li, Yulei, Peipei Liu, X. L. Wang, et al.. (2024). A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants. PLoS Pathogens. 20(9). e1012508–e1012508. 2 indexed citations

Xu, Kun, Yaling An, Haitang Xie, et al.. (2024). Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera. npj Vaccines. 9(1). 215–215. 8 indexed citations

Xu, Kun, et al.. (2024). Sequential Immunization with Vaccines Based on SARS-CoV-2 Virus-like Particles Induces Broadly Neutralizing Antibodies. Vaccines. 12(8). 927–927.

Li, Botong, Tiwei Chen, Li Zhang, et al.. (2024). Enhancement-mode Ga₂O₃ FETs with an unintentionally doped (001) β-Ga₂O₃ channel layer grown by metal-organic chemical vapor deposition. Japanese Journal of Applied Physics. 63(7). 70901–70901. 2 indexed citations

An, Yaling, Patrice Dubois, Yan Huang, et al.. (2023). Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE™. Vaccine. 41(17). 2793–2803. 4 indexed citations

Zheng, Yuxuan, Zhengrong Gao, Sheng Liu, et al.. (2023). Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine. Cell Discovery. 9(1). 79–79. 5 indexed citations

Zhang, Yanfang, Sheng Liu, Pu Han, et al.. (2023). Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7. PLoS Pathogens. 19(9). e1011659–e1011659. 7 indexed citations

10.

An, Yaling, Gan Zhao, Ning Zhang, et al.. (2023). Robust and protective immune responses induced by heterologous prime‐boost vaccination with DNA‐protein dimeric RBD vaccines for COVID‐19. Journal of Medical Virology. 95(7). e28948–e28948. 1 indexed citations

11.

Cao, Fengqiang, Sha Peng, Yaling An, et al.. (2023). Inside-out assembly of viral antigens for the enhanced vaccination. Signal Transduction and Targeted Therapy. 8(1). 189–189. 11 indexed citations

12.

Xu, Kun, Zihan Wang, Na Luo, et al.. (2023). A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults. Frontiers in Immunology. 14. 1113156–1113156. 29 indexed citations

13.

Xu, Kun, et al.. (2022). Immunogenicity, efficacy and safety of COVID-19 vaccines: an update of data published by 31 December 2021. International Immunology. 34(12). 595–607. 22 indexed citations

14.

Liu, Jiaojiao, Kun Xu, Man Xing, et al.. (2021). Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection. Cell Discovery. 7(1). 123–123. 21 indexed citations

15.

Bào, Yīmíng, Yuqing Zhang, Guanglin Lei, et al.. (2021). Integrated gut virome and bacteriome dynamics in COVID-19 patients. Gut Microbes. 13(1). 1–21. 95 indexed citations

16.

Dai, Lianpan, Kun Xu, Jinhe Li, et al.. (2021). Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch. Nature Immunology. 22(8). 958–968. 30 indexed citations

17.

Xu, Kun, et al.. (2018). Opportunities and Challenges of Tight Oil Development in China. 25(2). 17–23. 1 indexed citations

18.

Xu, Kun, Yufeng Song, Lianpan Dai, et al.. (2018). Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage. Journal of Virology. 92(6). 57 indexed citations

19.

Liu, William J., Min Zhao, Kefang Liu, et al.. (2016). T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV. Antiviral Research. 137. 82–92. 274 indexed citations breakdown →

20.

Wu, Xiaoming, et al.. (2001). Genetic divergence and phylogeny of Chinese Xinjiang wild rape, Sinapis arvensis and Brassica nigra. 23(4). 1–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact